Analysis of the bio- and nano-technological market of Germany to find market entry strategies for chosen IBM Research Developments
Business & Finance, Management & Leadership, Management
| Author: | Daniel Bartel | ISBN: | 9783640824649 |
| Publisher: | GRIN Publishing | Publication: | February 10, 2011 |
| Imprint: | GRIN Publishing | Language: | English |
| Author: | Daniel Bartel |
| ISBN: | 9783640824649 |
| Publisher: | GRIN Publishing |
| Publication: | February 10, 2011 |
| Imprint: | GRIN Publishing |
| Language: | English |
Essay from the year 2011 in the subject Business economics - Business Management, Corporate Governance, grade: keine, Baden-Wuerttemberg Cooperative State University (DHBW), course: Intercultural Management, language: English, abstract: In this seminar paper I want to discuss about IBM's efforts in the biotechnology and nanotechnology sector. As the lecture international management designated I will coin these efforts with strategies of market entry within Germany. I have chosen IBM, a US-based company, because it is highly involved in building future technologies. The Company is well known for its activities around the world and sees itself as a globally integrated enterprise. However, cultural attitudes of different countries still determine the success or failure of market entries. Germany is known as a technology-leading country. Also dealing with powerful NGO's the success of new market entry with modern technology might seems less predictable . In the first part of this paper I give a brief description about IBM, its research fields related to the topic and outline four research examples. Followed by an introduc-tion of Germany's cultural attitude to bio- and nanotechnology I provide some strategic suggestions on how IBM could manage the expansion of its efforts within the targeted country.
Essay from the year 2011 in the subject Business economics - Business Management, Corporate Governance, grade: keine, Baden-Wuerttemberg Cooperative State University (DHBW), course: Intercultural Management, language: English, abstract: In this seminar paper I want to discuss about IBM's efforts in the biotechnology and nanotechnology sector. As the lecture international management designated I will coin these efforts with strategies of market entry within Germany. I have chosen IBM, a US-based company, because it is highly involved in building future technologies. The Company is well known for its activities around the world and sees itself as a globally integrated enterprise. However, cultural attitudes of different countries still determine the success or failure of market entries. Germany is known as a technology-leading country. Also dealing with powerful NGO's the success of new market entry with modern technology might seems less predictable . In the first part of this paper I give a brief description about IBM, its research fields related to the topic and outline four research examples. Followed by an introduc-tion of Germany's cultural attitude to bio- and nanotechnology I provide some strategic suggestions on how IBM could manage the expansion of its efforts within the targeted country.
